Mission shRNA against ERβ was obtained from Sigma–Aldrich. Expression plasmid for HA-tagged mERβ (pSSH25-mERβ) was constructed by inserting PCR-amplified mERβ cDNA into pSHH25 [56 (link)] using XhoI and BlgII restriction sites. pSSH25-TDG for mammalian expression of HA-fused TDG [56 (link)], pPRS220 for yeast expression of Gal4-AD-fused TDG [46 (link)], 3× ERE-luc [47 (link)], and pSG5hERβ [57 (link)] used in luciferase assays have been published. pRL-TK for normalisation of luciferase activity was purchased from Promega. GST-ERβ was constructed by cloning cDNA encoding for human ERβ into pGEX-6P-3 (GE Healthcare) using BamHI and XhoI restriction sites. pACT2-ERβ was obtained by cloning cDNA encoding for human ERβ into pACT2 (Clontech) using SmaI and XhoI restriction sites. Antibodies used were as follows: rat monoclonal anti-HA (3F10) from Roche Applied Science, rabbit monoclonal anti-ERβ (05-824), rabbit polyclonal anti-H3K4m2 (07-030), and rabbit polyclonal anti-H3K27m3 (07-449) from Millipore, rabbit polyclonal anti-H3K9m3 (060-050) from Diagenode, and mouse monoclonal anti-Hsp90 (F-8) from Santa Cruz Biotechnology, Inc.
Free full text: Click here